
The Physical AI Shift in Post-Acute Care: Inside Inspiren's $500M+ Bet
Dr. Dereck Mush, MD, MBAVenture fund
NewView was founded in 2018 by Ravi Viswanathan, a former NEA general partner, and launched with a $1.35 billion fund that took over a group of NEA portfolio stakes. It can lead or follow, has no minimum ownership requirement, and offers operating help on go to market and financing. According to Inspiren's announcement, NewView manages more than $3 billion. It led Inspiren's $70 million Series C in September 2026, at a valuation above $500 million. Inspiren uses wall mounted sensors and AI in senior living communities to spot fall risk and alert caregivers.
NewView Capital is a venture growth firm that invests in enterprise technology, AI, and fintech companies, buying primary or secondary shares or both.
How NewView Capital got here, step by step.
2018
Ravi Viswanathan launches NewView as a spinout from NEA with a $1.35 billion first fund.
Venture fund
Corporate venture
Venture fund
Venture fund
Venture fund
Venture fund

Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBA
Dr. Dereck Mush, MD, MBAKeep exploring
Your daily HealthTech Signal
Get the latest HealthTech news, understand why it matters, and see where the industry is headed.



Read by teams at companies like: